Tecan Group AG / Tecan and Waters sign OEM agreement . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement.
- Tecan to supply instruments for sample preparation of Waters' clinical laboratory assays
- Waters will combine the Tecan platform with its own ACQUITY® TQD liquid chromatograph/mass spectrometer
- Commercial supply of instruments expected to start within the next six months
Männedorf, Switzerland, January 17, 2012 - The Tecan Group (SIX Swiss Exchange: TECN) today announced an OEM agreement with Waters Corporation (NYSE:WAT). Under the agreement, Tecan will supply instruments for the sample preparation of Waters' clinical laboratory assays. The instrument is based on Tecan's flexible and reliable Freedom EVO® liquid handling platform and will be used as a component of the Waters® system in combination with a Waters ACQUITY® TQD liquid chromatograph/mass spectrometer (LC/MS/MS).
Tecan expects to start the commercial supply of instruments within the next six months.
Financial details of the agreement were not disclosed.
Waters and ACQUITY are trademarks of Waters Corporation.
Tecan and Freedom EVO are trademarks of the Tecan Group Ltd.
About Tecan
Tecan (www.tecan.com (http://www.tecan.com/)) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2010, Tecan generated sales of CHF 371 million (USD 356 million; EUR 269 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN: 1210019).
About Waters Corporation For over 50 years, Waters Corporation (NYSE:WAT) has created business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.
Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.
With revenue of $1.64 billion in 2010 and 5,400 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.
For further information:
Tecan Group
Martin Braendle
Head of Corporate Communications & Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
investor@tecan.com (mailto:investor@tecan.com)
www.tecan.com (http://www.tecan.com)
Waters Corporation
Brian J. Murphy
Waters Corporation
Public Relations
+1 508-482-2614
brian_j_murphy@waters.com (mailto:brian_j_murphy@waters.com)
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Tecan Group AG via Thomson Reuters ONE
--- End of Message ---
Tecan Group AG
Seestrasse 103 Männedorf Switzerland
ISIN: CH0012100191;
